SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		6 Months Ended
	Apr. 30, 2026	Apr. 30, 2025	Apr. 30, 2026	Apr. 30, 2025
Product Information [Line Items]
FDIC insured amount	$ 250,000		$ 250,000
Cash balances	884,000		884,000
Revenues	2,581,000	$ 1,149,000	4,027,000	$ 2,239,000
Operating and finance lease obligation	$ 31,000	$ 42,000	$ 50,000	$ 48,000
Common shares issuable upon the exercise of options and warrants [Member]
Product Information [Line Items]
Antidilutive securities excluded from computation of earnings per share			4,649,857	3,591,721
Common Shares Unissued Shares Of Restricted Stock [Member]
Product Information [Line Items]
Antidilutive securities excluded from computation of earnings per share			295,000	228,333
Convertible Debt Securities [Member]
Product Information [Line Items]
Antidilutive securities excluded from computation of earnings per share			250,000	725,000
Common shares issuable upon the future payments [Member]
Product Information [Line Items]
Antidilutive securities excluded from computation of earnings per share			50,000
Large medical practice group and distributor [Member]
Product Information [Line Items]
Revenues			$ 571,000
Large medical practice group and distributor [Member] \| Revenue Benchmark [Member] \| Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration percentage			(14.20%)
Another large medical practice group and distributor [Member]
Product Information [Line Items]
Revenues			$ 511,000
Another large medical practice group and distributor [Member] \| Revenue Benchmark [Member] \| Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration percentage			(12.70%)
Large distributor [Member]
Product Information [Line Items]
Revenues				$ 270,000
Large distributor [Member] \| Revenue Benchmark [Member] \| Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration percentage				(12.10%)
Another large distributor [Member]
Product Information [Line Items]
Revenues				$ 341,000
Another large distributor [Member] \| Revenue Benchmark [Member] \| Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration percentage				(15.20%)
Two Individual Medical Practices [Member]
Product Information [Line Items]
Revenues				$ 228,000
Two Individual Medical Practices [Member] \| Revenue Benchmark [Member] \| Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration percentage				(10.20%)

Zeo ScientifiX, Inc. 10-Q